SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Net Sales
Revenue from contract with customer, excluding assessed tax	$ 385,191	$ 386,861	$ 1,159,644	$ 1,136,924
Segment Profit
Amortization	(3,141)	(4,113)	(10,339)	(12,838)
Operating income	65,049	56,439	171,080	139,007
Operating Segments
Segment Profit
Operating income	165,471	168,416	483,346	503,614
Corporate and other
Segment Profit
Operating income	(97,281)	(107,864)	(301,927)	(351,769)
Codman Specialty Surgical
Segment Net Sales
Revenue from contract with customer, excluding assessed tax	249,796	256,497	754,967	754,575
Codman Specialty Surgical | Operating Segments
Segment Profit
Operating income	105,717	110,686	308,073	331,460
Tissue Technologies
Segment Net Sales
Revenue from contract with customer, excluding assessed tax	135,395	130,364	404,677	382,349
Tissue Technologies | Operating Segments
Segment Profit
Operating income	$ 59,754	$ 57,730	$ 175,273	$ 172,154